Cosamin for FSI

SKU: COSMASU90

Advanced, Faster Acting Formula

Our advanced, faster acting formula, Cosamin ASU includes a combination of ingredients that works faster than glucosamine alone. It’s formulated with our trademarked glucosamine HCl, chondroitin sulfate, avocado/soybean unsaponifiables (ASU), AKBA...

Just added to your wishlist:
 
My Wishlist

More Information

Advanced, Faster Acting Formula

Our advanced, faster acting formula, Cosamin ASU includes a combination of ingredients that works faster than glucosamine alone. It’s formulated with our trademarked glucosamine HCl, chondroitin sulfate, avocado/soybean unsaponifiables (ASU), AKBA (from Boswellia serrata), and decaffeinated green tea extract providing EGCG.

About Cosamin ASU:

  • • 1500 mg Glucosamine HCl (FCHG49®)
  • • 350 mg Chondroitin Sulfate (TRH122®)
  • • 400 mg of a proprietary blend that includes NMX1000® ASU, QUIKLOX® AKBA, and Decaffeinated Green Tea Extract
  • • No FD&C Dyes
  • • Gluten-Free

Ingredients in Cosamin®ASU:

FCHG49® Glucosamine HCl and TRH122® Chondroitin Sulfate – The combination has been shown in cell culture research to decrease levels of markers associated with cartilage breakdown and joint discomfort.

ASU (NMX1000®) and AKBA (QUIKLOX®) from Boswellia serrata - have been shown to decrease prostaglandin E2 (PGE2), a signaling molecule associated with cartilage breakdown. AKBA is an ingredient scientifically researched to be faster acting than glucosamine alone.

Green Tea Extract (providing EGCG) - provides antioxidant benefits.

 

*THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE.


1 Laboratory studies show that the combination of ingredients in Cosamin®ASU decreases levels of markers associated with cartilage breakdown and reduced joint comfort.*
2 Clinical Pharmacokinetics 50, 349-369, 2011.
3 Molecular and Cellular Biochemistry 354, 189-197, 2011.
4 Arthritis Research & Therapy 10, R85, 2008.
Clinical Pharmacokinetics, 50, 349-369, 2011. Molecular and Cellular Biochemistry 354, 189-197, 2011. Arthritis Research & Therapy 10, R85, 2008.

Supplement Facts

Success Stories